EUVIMEDEUVIMED entdecken
Crossref

Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr- deficient mice

Doriane Henry iD, Eric Baugé, Nathalie Hennuyer iD, Kevin Ory iD, Bruno Derudas, Emmanuelle Vallez, Audrey Deprince iD, Philippe Lefebvre iD, Joel T Haas iD, Bart Staels iD, Fanny Lalloyer iD

Science Translational Medicine · 28.05.2025 · 17 (800)

DOI: 10.1126/scitranslmed.adj8192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 28.05.2025. Verfasst von Doriane Henry und 10 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France. Hauptthemen laut MEDLINE: PPAR alpha, Atherosclerosis, Hepatocytes, Receptors, LDL. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 90 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherogenic dyslipidemia and chronic inflammation appear strongly associated with residual cardiovascular disease (CVD) risk. Peroxisome proliferator–activated receptor α (PPARα) agonists, which exert both triglyceride-lowering and anti-inflammatory properties, are potential therapeutic candidates to target residual CVD risk. However, CVD outcome studies with these drugs have yielded mixed results for currently unclear reasons. In this study, we compared the impact of hepatocyte anti-inflammatory (transrepression) versus lipid-lowering (transactivation) properties of PPARα agonism on atherosclerosis in Ldlr −/− mice. PPARα agonist treatment reduced aortic atherosclerotic plaque surface in Western diet–fed Ldlr −/− mice expressing in hepatocytes either PPARα WT or a transrepression-selective PPARα mutant (PPARα DISS ), despite the lack of atherogenic dyslipidemia improvement with PPARα DISS . Mechanistically, ligand-activated hepatocyte-specific transrepressive PPARα activity decreased the pro-inflammatory phenotype of hepatocytes, lowered the recruitment of leukocytes in the liver, reduced plasma IL-1β concentrations, and decreased atherosclerotic plaque macrophage content. These findings identify a distal effect of hepatic PPARα on vascular integrity rather linked to its anti-inflammatory activity than its lipid-lowering actions and highlight an essential role of targeting inflammation in CVD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR alphaAtherosclerosisHepatocytesReceptors, LDLAnti-Inflammatory AgentsAnimalsMice, KnockoutInflammationMicePlaque, AtheroscleroticMaleLiverMice, Inbred C57BLHypolipidemic AgentsMacrophages

Substanzen

PPAR alphaReceptors, LDLAnti-Inflammatory AgentsHypolipidemic Agents

Autor:innen und Institutionen

  • Univ. Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1011-EGID, F-59000 Lille, France.

ORCID-Profile: Doriane Henry, Nathalie Hennuyer, Kevin Ory, Audrey Deprince, Philippe Lefebvre, Joel T Haas, Bart Staels, Fanny Lalloyer

Zitieren

APA

Henry, D., Baugé, E., Hennuyer, N., Ory, K., Derudas, B., Vallez, E., Deprince, A., Lefebvre, P., Haas, J. T., Staels, B., & Lalloyer, F. (2025). Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr- deficient mice. Science Translational Medicine, 17(800). https://doi.org/10.1126/scitranslmed.adj8192

Vancouver

Henry D, Baugé E, Hennuyer N, Ory K, Derudas B, Vallez E, et al. Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr- deficient mice. Science Translational Medicine. 2025;17(800). doi:10.1126/scitranslmed.adj8192

BibTeX
@article{Henry2025,
  author = {Henry, Doriane and Baugé, Eric and Hennuyer, Nathalie and Ory, Kevin and Derudas, Bruno and Vallez, Emmanuelle and Deprince, Audrey and Lefebvre, Philippe and Haas, Joel T and Staels, Bart and Lalloyer, Fanny},
  title = {Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr- deficient mice},
  journal = {Science Translational Medicine},
  year = {2025},
  volume = {17},
  number = {800},
  doi = {10.1126/scitranslmed.adj8192}
}
Kostenlos starten →